GENMAB A/S (GMAB) Form 6-K — Sep 8, 2026
Genmab A/S announced on September 8, 2026 that it will increase its share capital by 28,011 shares as a consequence of employee warrant exercises, generating proceeds of approximately DKK 44.3 million for the company. The new shares were subscribed in cash at prices ranging from DKK 1,334.50 to DKK 1,948.00 per share and were issued without preemption rights for existing shareholders. They represent approximately 0.04% of the company's share capital, bringing total shares outstanding to 62,405,855.
Key figures
- Gross Proceeds
- DKK 44.3 million
- Shares Offered
- 28011
- Shares Outstanding
- 62405855
- Subscription Tiers
- ["4,409 shares at DKK 1,334.50","1,464 shares at DKK 1,362.50","20,270 shares at DKK 1,615.00","1,868 shares at DKK 1,948.00"]
- Nominal Value Per Share DKK
- 1
- Total Nominal Share Capital DKK
- 62405855
- Dilution Percent Of Share Capital
- approximately 0.04%
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.